Description
PRINCIPIO ACTIVO: CLORURO DE SODIO
FORMA FARMACÉUTICA: 1 UNGÜENTO
Sandoz GmbH
Tratamiento del síndrome de dificultad respiratoria en neonatos prematuros
KLARICID-HP 500 MG 14 TAB PADS FACIALES 60.00 PZA PRINCIPIO ACTIVO: CLORURO DE SODIOPRINCIPIO ACTIVO: CLARITROMICINA DOSIS: 500 MG FORMA FARMACUTICA: 14 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
